Concord Medical Is Shortlisted for the "5G+Healthcare" Pilot Project

Rhea-AI Summary

Concord Medical Services Holdings Limited (NYSE: CCM) announced two projects shortlisted for the '5G+Healthcare' pilot project by China's Ministry of Industry and Information Technology. The projects include the Jiahe Cloud Imaging Remote Medical Information Diagnosis Platform, which offers solutions for remote diagnosis, and the Jiahe Feiyun Intelligent Radiotherapy Cloud Service Platform, providing comprehensive radiotherapy management services. This recognition highlights Concord's commitment to advancing cancer care in China through technology.

Positive

• Concord Medical's projects were shortlisted for the prestigious '5G+Healthcare' pilot project.
• Jiahe Cloud offers advanced remote diagnosis solutions, enhancing healthcare access.
• Jiahe Feiyun provides comprehensive services in radiotherapy, facilitating better patient outcomes.

Negative

• None.

BEIJING, Oct. 18, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that two projects of it, Jiahe Cloud Imaging Remote Medical Information Diagnosis Platform ("Jiahe Cloud") and Jiahe Feiyun Intelligent Radiotherapy Cloud Service Platform ("Jiahe Feiyun"), were successfully shortlisted by the "5G+Healthcare" pilot project, which is launched by Ministry of Industry and Information Technology.

Jiahe Cloud provides digitized solutions, with remote diagnosis as the core service, for medical institutions. The platform consists of six modules: reginal imaging remote diagnosis, bilateral referral, remote clinical consultation, remote training, cloud filming and report, and remote ECG/ pathology/ ultrasound diagnosis.

Jiahe Feiyun is one of the six shortlisted radiotherapy projects of the "5G+Healthcare" pilot project. It is a comprehensive service platform that provides a variety of services including radiotherapy process management, target area delineation, clinical cooperation among doctors, remote quality control, multidisciplinary treatment, remote training, big data analysis, etc.

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider specialized in cancer treatment, research, education and prevention. The Company operates a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centres in China. The Company focuses on providing multidisciplinary cancer care approach in all areas of oncology services in its cancer hospitals. The Company also equips its hospitals with technologically advanced equipment such as the state-of-the-art proton therapy system in its premium cancer hospitals in top-tier cities including Beijing, Shanghai, and Guangzhou. In addition, the Company saw the opportunity of the expanding market of medical equipment in China and developed its product life-cycle management services form its existing medical equipment and consumable sales services. As of December 31, 2020, the Company operated a network of 27 radiotherapy centers and diagnostic imaging centers, which are based in 20 hospitals, established under long-term lease and management services arrangements with the Company and spanning over 20 cities across 13 provinces and administrative regions in China. To ensure the commitment to the highest standard of medical services for patients, the Company offers ongoing education and training for doctors and other medical professionals in its network hospitals and centres in both domestic and overseas medical institutions.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

see http://ir.ccm.cn.

View original content:https://www.prnewswire.com/news-releases/concord-medical-is-shortlisted-for-the-5ghealthcare-pilot-project-301402023.html

SOURCE Concord Medical Services Holdings Limited

FAQ

What is the significance of Concord Medical's projects being shortlisted for the 5G+Healthcare pilot project?

The shortlisting indicates recognition of Concord Medical's innovative approaches in cancer care and could enhance its market position.

What are the main features of the Jiahe Cloud Imaging platform?

The Jiahe Cloud platform includes six modules focused on remote diagnosis, consultations, training, and imaging services for medical institutions.

When was the announcement made regarding Concord Medical's projects?

The announcement was made on October 18, 2021.

What does Jiahe Feiyun Intelligent Radiotherapy Cloud Service Platform offer?

It provides services including radiotherapy management, remote quality control, and multidisciplinary treatment.

How does Concord Medical's recognition in the pilot project affect its business?

This recognition may enhance Concord Medical's credibility and attract potential partnerships and investments in advanced cancer care.